Pneumonia Therapeutics Market Analysis By Product (Drugs, Vaccine, Oxygen Therapy), By Infection (HAP, CAP, VAP), By Route of Administration (Oral, Parenteral, Others), By End Use, By Region And Segment Forecasts, 2024 - 2030
Select a license type that suits your business needs
Individual License
US $5,950
Five thousand nine hundred fifty
- Report accessible by 1 user only
- Free 15% or 32 hours of customisation
- Free post-sale service assistance
- Direct access to lead analysts
- Report delivery on Compass (our interactive cloud platform)
Frequently purchased
Team License
US $6,950
Six thousand nine hundred fifty
- Report accessible by up to 5 users
- Free 25% or 54 hours of customisation
- Free access to report summaries
- Direct access to lead analysts
- 25% discount on your next purchase
- Report delivery on Compass (our interactive cloud platform)
- Service guarantee available (Full/partial refund in case of quality concerns)
- Dedicated account manager
- Personalised market brief by the lead author
- Permission to print the report
Enterprise License
US $8,950
Eight thousand nine hundred fifty
- All team license features plus
- Free 30% or 64 hours of customisation
- Unlimited user access (Within your organization)
- Exclusive previews of upcoming research & latest releases
- 30% discount on your next purchase
- Customisable dashboards on Compass
